To suggest that ANY DTC ads are too distracting for fair balance information clearly shows just how out of touch the FDA is with the methods patients make healthcare decisions (read “FDA Cites TV Ads for ‘Compelling’ ‘Attention-Grabbing’ Distractions That Undermine Communication of Risks”: http://sco.lt/5U3O2D).
Will the FDA ever accept the fact that DTC ads, on TV, are not as effective as they once were and that patients are not going to run to their doctor to “ask for an Rx” after viewing a TV spot?
According to a 2016 STAT-Harvard poll, only 7% of consumer respondents were motivated to talk to their physician about a prescription drug they saw on TV, down from 21% in 2015. That’s 93% ineffective! Yet the FDA really believes that drug companies have this hidden power of persuasion and consumers make treatment decisions based on a commercial. How sad.
The poll also indicated that 57% of U.S. adults support ending Rx drug TV advertising. So then why would DTC managers continue to invest in TV?
The FDA could better protect health information seekers by helping patients get good, easy to read, credible information not with saying ads are too distracting.